FDA NDC Directory · JSON-LD · Markdown

LUCENTIS

NDC 50242-082 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameRANIBIZUMAB
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA125156
Dosage form / routeINJECTION, SOLUTION · INTRAVITREAL
Active ingredientsRANIBIZUMAB (6 mg/mL)
Marketing started20120810
Package count2

External sources

Source: openFDA. Public-domain (CC0).